Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Denton, Paul W.
    • Other Affiliation: University of Texas Southwestern Medical Center at Dallas
  • Krisko, John F.
    • Other Affiliation: University of Texas Southwestern Medical Center at Dallas
  • Powell, Daniel A.
    • Other Affiliation: University of Texas Southwestern Medical Center at Dallas
  • Mathias, Melissa
    • Other Affiliation: University of Texas Southwestern Medical Center at Dallas
  • Kwak, Youn Tae
    • Other Affiliation: University of Texas Southwestern Medical Center at Dallas
  • Martinez-Torres, Francisco
    • Other Affiliation: University of Texas Southwestern Medical Center at Dallas
  • Zou, Wei
    • Other Affiliation: University of Texas Southwestern Medical Center at Dallas
  • Payne, Deborah A.
    • Other Affiliation: University of Texas Southwestern Medical Center at Dallas
  • Estes, Jacob D.
    • Other Affiliation: National Cancer Institute
  • Garcia, J. Victor
    • Affiliation: School of Medicine, Center for AIDS Research
Abstract
  • Successful antiretroviral pre-exposure prophylaxis (PrEP) for mucosal and intravenous HIV-1 transmission could reduce new infections among targeted high-risk populations including discordant couples, injection drug users, high-risk women and men who have sex with men. Targeted antiretroviral PrEP could be particularly effective at slowing the spread of HIV-1 if a single antiretroviral combination were found to be broadly protective across multiple routes of transmission. Therefore, we designed our in vivo preclinical study to systematically investigate whether rectal and intravenous HIV-1 transmission can be blocked by antiretrovirals administered systemically prior to HIV-1 exposure. We performed these studies using a highly relevant in vivo model of mucosal HIV-1 transmission, humanized Bone marrow/Liver/Thymus mice (BLT). BLT mice are susceptible to HIV-1 infection via three major physiological routes of viral transmission: vaginal, rectal and intravenous. Our results show that BLT mice given systemic antiretroviral PrEP are efficiently protected from HIV-1 infection regardless of the route of exposure. Specifically, systemic antiretroviral PrEP with emtricitabine and tenofovir disoproxil fumarate prevented both rectal (Chi square = 8.6, df = 1, p = 0.003) and intravenous (Chi square = 13, df= 1, p = 0.0003) HIV-1 transmission. Our results indicate that antiretroviral PrEP has the potential to be broadly effective at preventing new rectal or intravenous HIV transmissions in targeted high risk individuals. These in vivo preclinical findings provide strong experimental evidence supporting the potential clinical implementation of antiretroviral based pre-exposure prophylactic measures to prevent the spread of HIV/AIDS.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
License
  • Public Domain Mark 1.0
Journal title
  • PLoS ONE
Journal volume
  • 5
Journal issue
  • 1
Language
  • English
ISSN
  • 1932-6203

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details journal.pone.0008829.PDF 2020-06-11 Public Download